Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1953 2
1973 1
1974 1
1975 1
1976 3
1977 3
1978 5
1979 4
1980 1
1981 3
1982 4
1983 4
1984 1
1986 3
1987 2
1988 2
1990 5
1991 2
1992 2
1994 6
1995 2
1997 6
1998 3
1999 3
2000 4
2001 7
2002 6
2003 2
2004 2
2005 2
2006 6
2007 2
2008 2
2009 5
2010 6
2011 9
2012 4
2013 10
2014 9
2015 5
2016 13
2017 14
2018 12
2019 9
2020 8
2021 14
2022 20
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Johnston SC, et al. N Engl J Med. 2018 Jul 19;379(3):215-225. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16. N Engl J Med. 2018. PMID: 29766750 Free PMC article. Clinical Trial.
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A, Clark W, Coull B, Ford GA, Kleindorfer D, O'Leary JR, Parsons MW, Ringleb P, Sen S, Spence JD, Tanne D, Wang D, Winder TR; IRIS Trial Investigators. Kernan WN, et al. N Engl J Med. 2016 Apr 7;374(14):1321-31. doi: 10.1056/NEJMoa1506930. Epub 2016 Feb 17. N Engl J Med. 2016. PMID: 26886418 Free PMC article. Clinical Trial.
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Derdeyn CP, et al. Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26. Lancet. 2014. PMID: 24168957 Free PMC article. Clinical Trial.
Wilderness Medicine.
Alexander W, Bright S, Burns P, Townes D. Alexander W, et al. Among authors: bright s. Med Clin North Am. 2016 Mar;100(2):345-56. doi: 10.1016/j.mcna.2015.09.003. Epub 2016 Jan 14. Med Clin North Am. 2016. PMID: 26900118 Review.
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.
Dimopoulos MA, Hungria VTM, Radinoff A, Delimpasi S, Mikala G, Masszi T, Li J, Capra M, Maiolino A, Pappa V, Chraniuk D, Osipov I, Leleu X, Low M, Matsumoto M, Sule N, Li M, McKeown A, He W, Bright S, Currie B, Perera S, Boyle J, Roy-Ghanta S, Opalinska J, Weisel K. Dimopoulos MA, et al. Among authors: bright s. Lancet Haematol. 2023 Oct;10(10):e801-e812. doi: 10.1016/S2352-3026(23)00243-0. Lancet Haematol. 2023. PMID: 37793771 Clinical Trial.
The future impacts of non-targeted effects.
Bright S, Kadhim M. Bright S, et al. Int J Radiat Biol. 2018 Aug;94(8):727-736. doi: 10.1080/09553002.2018.1454617. Epub 2018 Apr 11. Int J Radiat Biol. 2018. PMID: 29569509 Review.
To improve quality, leverage design.
Crowe B, Gaulton JS, Minor N, Asch DA, Eyet J, Rainosek E, Flint K, Joo J, Chambers C, Bright S, Yang JJ, Beyt G, Pierce R, Moses JM. Crowe B, et al. Among authors: bright s. BMJ Qual Saf. 2022 Jan;31(1):70-74. doi: 10.1136/bmjqs-2021-013605. Epub 2021 Sep 11. BMJ Qual Saf. 2022. PMID: 34510018 Free PMC article. No abstract available.
Signaling COVID-19 Vaccine Adverse Events.
Harpaz R, DuMouchel W, Van Manen R, Nip A, Bright S, Szarfman A, Tonning J, Lerch M. Harpaz R, et al. Among authors: bright s. Drug Saf. 2022 Jul;45(7):765-780. doi: 10.1007/s40264-022-01186-z. Epub 2022 Jun 23. Drug Saf. 2022. PMID: 35737293 Free PMC article.
235 results